13D/13G Filings - Beam Therapeutics Inc. (BEAM)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-02-16
4:06 pm
Purchase
2020-12-31 13G Beam Therapeutics Inc.
BEAM
Redmile Group LLC 3,778,262
6.500%
3,778,262increase
(New Position)
Filing
History
2021-02-08
10:17 am
Purchase
2021-02-05 13G Beam Therapeutics Inc.
BEAM
FMR CORP 7,328,586
12.642%
356,674increase
(+5.12%)
Filing
History
2021-02-05
06:06 am
Purchase
2020-02-06 13G Beam Therapeutics Inc.
BEAM
TEMASEK HOLDINGS LTD 3,354,641
5.700%
3,354,641increase
(New Position)
Filing
History
2021-02-02
4:13 pm
Purchase
2020-12-31 13G Beam Therapeutics Inc.
BEAM
ARCH Venture Fund IX, L.P. 8,243,039
13.500%
8,243,039increase
(New Position)
Filing
History
2021-02-02
3:13 pm
Purchase
2020-12-31 13G Beam Therapeutics Inc.
BEAM
BLACKROCK INC
BLK
3,159,510
5.500%
3,159,510increase
(New Position)
Filing
History
Goto Prev, 0, 1, 2